Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025267 · ClinicalTrials.gov registry record · NA
Ability to Meet Enteral Nutritional Needs with a Peptide-based, High Protein Formula
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05025267: Completed NA study, sponsored by Société des Produits Nestlé (SPN).
NCT05025267 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05025267, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a prospective, open-label single-arm observational clinical trial to assess enteral feeding nutrition goals with a peptide-based, high protein enteral formula.
Primary Outcome
Daily percentage of calorie nutritional goals met
Interventions
- OTHER Medical Food: Peptide-Based Enteral Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-01-31 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT05025267 record still lists
NCT05025267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Medical Food: Peptide-Based Enteral Formula is the first listed.
NCT05025267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05025267 about?
NCT05025267 is a clinical study titled "Ability to Meet Enteral Nutritional Needs with a Peptide-based, High Protein Formula". This is a prospective, open-label single-arm observational clinical trial to assess enteral feeding nutrition goals with a peptide-based, high protein enteral formula.
What is the current status of trial NCT05025267?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-01-31. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT05025267?
The interventions under investigation include: Medical Food: Peptide-Based Enteral Formula (OTHER).
Who is sponsoring clinical trial NCT05025267?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05025267's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI